Bookmark

Add to MyYahoo RSS

Foradil, Formoterol News

News on Foradil, Formoterol (generic) continually updated from thousands of sources around the net.

Wednesday Aug 6 | In-PharmaTechnologist.com

Actavis welcomes AZ in boosting its LAMA/LABA

Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist fixed dose combination respiratory drug following the latter's acquisition of Almirall.

Comment?

Related Topix: Spain, World News, Copd, Medicine, Health, Asthma, Forest Laboratories, Biotech, Forest Labs, Healthcare Industry

Mon Aug 04, 2014

In-PharmaTechnologist.com

AstraZeneca coughs up $875m for Almirall to support asthma/COPD pipeline

The total price of the Barcelona, Spain-headquartered pharma firm could reach $1.22bn following development, launch, and sales-related milestones, but its respiratory assets will strengthen the Pharma Giant's inhaled asthma and COPD portfolio, adding to the inhaler and particle technology acquired in the $1.5bn Pearl Therapeutics transaction in ... (more)

Comment?

Related Topix: Medicine, Asthma, Health, Copd, Spain, World News, Pulmicort, Budesonide (generic)

Sat Aug 02, 2014

Big News Network.com

AstraZeneca agrees to strategic transaction with Almirall in respiratory disease

Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.

Comment?

Related Topix: Copd, Medicine, Marketing

Thu Jul 31, 2014

Chemistry World

AstraZeneca stocks respiratory and cancer pipelines

AstraZeneca has agreed to buy Spanish firm Almirall's respiratory drug assets for $875 million up front, plus up to $1.2 billion in performance milestone payments.

Comment?

Related Topix: Medicine, Asthma, Oncology

Wed Jul 30, 2014

GlobeNewswire

Strategic Respiratory Transaction with Almirall

ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's respiratory franchise with a complementary pipeline and inhaled device capabilities in asthma and COPD AstraZeneca today announced that it has entered an ... (more)

Comment?

Related Topix: Biotech, AstraZeneca Group, Copd, Health, Asthma

•••
•••
•••
•••
•••
•••
•••